A preliminary study by Israel’s Ministry of Health found that amid the spread of the coronavirus’s Delta variant, the Pfizer-BioNTech COVID-19 vaccine is only 64 percent effective (Times of Israel) in preventing symptomatic illness. When the Delta variant was less prevalent in Israel in May, the vaccine was 94 percent effective.
